Logo image of AYRO

AYRO INC (AYRO) Stock Fundamental Analysis

NASDAQ:AYRO - Nasdaq - US0547482077 - Common Stock - Currency: USD

6.14  +0.26 (+4.42%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AYRO. AYRO was compared to 37 industry peers in the Automobiles industry. AYRO has a great financial health rating, but its profitability evaluates not so good. AYRO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

AYRO had negative earnings in the past year.
AYRO had a negative operating cash flow in the past year.
AYRO had negative earnings in each of the past 5 years.
In the past 5 years AYRO always reported negative operating cash flow.
AYRO Yearly Net Income VS EBIT VS OCF VS FCFAYRO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

AYRO's Return On Assets of -42.87% is on the low side compared to the rest of the industry. AYRO is outperformed by 64.86% of its industry peers.
AYRO has a Return On Equity of -108.71%. This is comparable to the rest of the industry: AYRO outperforms 43.24% of its industry peers.
Industry RankSector Rank
ROA -42.87%
ROE -108.71%
ROIC N/A
ROA(3y)-57.57%
ROA(5y)-48.35%
ROE(3y)-99.82%
ROE(5y)-74.6%
ROIC(3y)N/A
ROIC(5y)N/A
AYRO Yearly ROA, ROE, ROICAYRO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AYRO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AYRO Yearly Profit, Operating, Gross MarginsAYRO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K

More info and screens

7

2. Health

2.1 Basic Checks

AYRO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AYRO has been increased compared to 1 year ago.
The number of shares outstanding for AYRO has been increased compared to 5 years ago.
AYRO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AYRO Yearly Shares OutstandingAYRO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100K 200K 300K 400K 500K
AYRO Yearly Total Debt VS Total AssetsAYRO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -11.35, we must say that AYRO is in the distress zone and has some risk of bankruptcy.
AYRO's Altman-Z score of -11.35 is on the low side compared to the rest of the industry. AYRO is outperformed by 70.27% of its industry peers.
AYRO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -11.35
ROIC/WACCN/A
WACC8.91%
AYRO Yearly LT Debt VS Equity VS FCFAYRO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

AYRO has a Current Ratio of 2.20. This indicates that AYRO is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of AYRO (2.20) is better than 86.49% of its industry peers.
A Quick Ratio of 2.20 indicates that AYRO has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.20, AYRO belongs to the best of the industry, outperforming 94.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 2.2
AYRO Yearly Current Assets VS Current LiabilitesAYRO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

0

3. Growth

3.1 Past

AYRO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.90%, which is quite impressive.
The Revenue for AYRO has decreased by -98.79% in the past year. This is quite bad
Measured over the past years, AYRO shows a very negative growth in Revenue. The Revenue has been decreasing by -41.10% on average per year.
EPS 1Y (TTM)84.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.54%
Revenue 1Y (TTM)-98.79%
Revenue growth 3Y-71.3%
Revenue growth 5Y-41.1%
Sales Q2Q%-100%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AYRO Yearly Revenue VS EstimatesAYRO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
AYRO Yearly EPS VS EstimatesAYRO Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AYRO. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AYRO Price Earnings VS Forward Price EarningsAYRO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AYRO Per share dataAYRO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AYRO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AYRO INC

NASDAQ:AYRO (8/11/2025, 8:17:47 PM)

6.14

+0.26 (+4.42%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)05-14 2025-05-14
Earnings (Next)08-13 2025-08-13
Inst Owners3.66%
Inst Owner Change-34.77%
Ins Owners2.06%
Ins Owner Change0%
Market Cap3.32M
Analysts82.86
Price TargetN/A
Short Float %N/A
Short Ratio0.22
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 614
P/FCF N/A
P/OCF N/A
P/B 0.52
P/tB 0.52
EV/EBITDA N/A
EPS(TTM)-20.35
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-19.09
FCFYN/A
OCF(TTM)-18.72
OCFYN/A
SpS0.01
BVpS11.8
TBVpS11.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -42.87%
ROE -108.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-57.57%
ROA(5y)-48.35%
ROE(3y)-99.82%
ROE(5y)-74.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.2
Quick Ratio 2.2
Altman-Z -11.35
F-Score2
WACC8.91%
ROIC/WACCN/A
Cap/Depr(3y)134.5%
Cap/Depr(5y)126.45%
Cap/Sales(3y)268.35%
Cap/Sales(5y)171.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.9%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.54%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-98.79%
Revenue growth 3Y-71.3%
Revenue growth 5Y-41.1%
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y61.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y53.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.73%
OCF growth 3YN/A
OCF growth 5YN/A